CNS TUMOR
Clinical trials for CNS TUMOR explained in plain language.
Never miss a new study
Get alerted when new CNS TUMOR trials appear
Sign up with your email to follow new studies for CNS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a drug called avapritinib in children and teenagers (ages 2 to 18) with advanced solid tumors, including brain tumors, that had come back or stopped responding to standard treatments. The trial aimed to find a safe dose and see if the drug could shrink tumors in…
Matched conditions: CNS TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New brain scan dye tested as safer alternative
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…
Matched conditions: CNS TUMOR
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
Doctors track brain tumor patients to see how treatment works in real life
Knowledge-focused CompletedThis study observed 272 adult brain tumor patients who received Gliadel wafers as part of their normal medical care. Researchers tracked patients for up to three years to collect real-world information on how long patients lived, whether their cancer returned, and what side effec…
Matched conditions: CNS TUMOR
Sponsor: Arbor Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 06, 2026 15:37 UTC